Advances in Therapy

SJR Rank #2,680H-index: 99SJR: 1.418Best quartile: Q1APC: US$4,790
Journal website: aims, scope and author guidelines
Publisher

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.40.81.21.6

Subject Categories

  • Medicine (miscellaneous)Q1
  • Pharmacology (medical)Q1

Areas: Medicine

Most published research topics

Diabetes Treatment and ManagementAsthma and respiratory diseasesRheumatoid Arthritis Research and TherapiesDiabetes Management and ResearchGlaucoma and retinal disordersRetinal Diseases and TreatmentsChronic Obstructive Pulmonary Disease (COPD) ResearchBlood Pressure and Hypertension StudiesBiosimilars and Bioanalytical MethodsDiabetes, Cardiovascular Risks, and Lipoproteins

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs02505007501000

Documents per Year

20222025095190285380

Detailed Information

ISSN

0741-238X, 1865-8652

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

4.52

References per Document

42.61

Coverage

1984-2026

Scope

Advances in Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged. The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Advances in Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.

Metrics from SCImago Journal Rank 2025. View on SCImago